Novo Nordisk and Indian partner Torrent Pharmaceuticals will expand insulin production in India.

Sanofi is recalling a lot of its injected gel for treating arthritis in knees in the U.S. which has tested positive for microbial contamination.

A Bangladeshi company that would like to sell an  antibiotic in the U.K. has been stopped before it started.

A Glenmark plant in Baddi has been cited by the FDA for a variety of problems including questions on the unauthorized destruction of quality records.

CSL has opened the first phase of a $170 million plasma products plant in Australia that will add 200 jobs to the 1,000 already at the site.

China’s WuXi Biologics says its new $150 million, 30,000-liter capacity biologics plant is up and running, a feat it accomplished in less than three years.

Contractor ADC Biotechnology is moving quickly to get a manufacturing facility built in Wales to produce its new ADCs.

CDMO Albany Molecular Research Inc., which was recently acquired by private investors, has bulked up its aseptic API capacity.

A U.S. unit of Japan’s Daiichi Sankyo that makes sterile injectable drugs will invest $145 million to expand facilities in Ohio, adding 80 jobs in the process…